Today: 9 April 2026
Subscribe
Browse Category

NYSE:LDI 9 January 2026 - 27 March 2026

Mortgage Rates Today: 30-Year Rate Climbs to 6.64% as Rocket, UWM and loanDepot Stock Prices Slip

Mortgage Rates Today: 30-Year Rate Climbs to 6.64% as Rocket, UWM and loanDepot Stock Prices Slip

U.S. mortgage rates rose again Friday, with Mortgage News Daily reporting the average 30-year fixed loan at 6.64%, an eight-month high. The Mortgage Bankers Association said mortgage applications fell 10.5% last week as rates climbed. Rocket Companies shares dropped to $13.66, while UWM Holdings and loanDepot also declined. The 10-year Treasury yield hovered at 4.44% and consumer sentiment hit a three-month low.
27 March 2026
···
Rocket Companies stock jumps 8% as RKT swings on mortgage volume talk

Rocket Companies stock jumps 8% as RKT swings on mortgage volume talk

Rocket Companies shares jumped 8.2% to $20.32 late Tuesday, with trading volume near 44.6 million shares. CEO Varun Krishna told CNBC the firm is seeing its highest mortgage loan volume and gain-on-sale margin in four years. UWM Holdings, loanDepot, and PennyMac Financial Services all fell. Rocket reports earnings Feb. 19.
3 February 2026
·······
Mortgage rates today hover near 6.2% as Rocket stock slips in premarket

Mortgage rates today hover near 6.2% as Rocket stock slips in premarket

Rocket Companies fell 0.6% to $23.14 in premarket trading Monday, retreating after Friday’s housing-driven rally. Mortgage rates hovered near 6.2% as the White House directed $200 billion in government-backed mortgage bond purchases, with an initial $3 billion round underway. loanDepot dropped 2.1% premarket. Investors await Tuesday’s U.S. inflation data.
12 January 2026
······
Rocket Companies stock jumps nearly 10% on Trump’s $200B mortgage-bond plan — what to watch next

Rocket Companies stock jumps nearly 10% on Trump’s $200B mortgage-bond plan — what to watch next

Rocket Companies shares jumped 9.6% to $23.29 Friday after President Trump ordered a $200 billion mortgage bond purchase to push down rates. loanDepot soared 24%, UWM Holdings rose 11.6%, and Opendoor climbed nearly 19%. Fannie Mae and Freddie Mac will handle the bond buys, but officials declined to give details. Markets reopen Monday as investors watch for follow-through.
11 January 2026
·····
Offerpad (OPAD) stock jumps in premarket after Trump mortgage-bond plan lifts housing shares

Offerpad (OPAD) stock jumps in premarket after Trump mortgage-bond plan lifts housing shares

Offerpad Solutions shares surged 36.8% premarket to $2.08 after President Trump announced a $200 billion mortgage bond-buying plan using Fannie Mae and Freddie Mac. The stock had closed Thursday at $1.52 and hit $2.40 after hours. Rival Opendoor and mortgage lenders also gained. Economists expect limited impact on rates and caution over Fannie and Freddie’s reserves.
9 January 2026
······

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:08 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Go toTop